Drug or treatment

Sevabertinib clinical trials

As of November 12, 2026, Find a Trial lists 3 clinical trials of Sevabertinib that are recruiting, at sites in 36 countries (most in China (3), Australia (2), Canada (2)). 1 was first registered in the last 30 days. By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Sevabertinib in HER2-mutant Advanced NSCLC: Real-world Outcomes — Qionghai, Hainan Recruiting Oct 19, 2026
Treatment for solid tumors with HER2 mutations using BAY2927088 tablets Phase 2 Birmingham, Alabama and 53 other locations Recruiting Jan 7, 2025
Evaluating BAY 2927088 for Advanced Lung Cancer with HER2 Mutations Phase 3 Newport Beach, California and 278 other locations Recruiting Jun 11, 2024

All recruiting trials (3)

Quick answers

How many clinical trials of Sevabertinib are recruiting right now?

3, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 36 countries. The most sites are in China (3 trials), Australia (2 trials), Canada (2 trials), Denmark (2 trials), France (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.